X
20
Cadila Healthcare Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLOPIDOGREL BISULFATE USP (FORM-I) (CUE ROUTE), with a corresponding US DMF Number 23439.
Remarkably, this DMF maintains an Inactive status since its submission on January 07, 2010, highlighting commitment to regulatory compliance.